CJ, Y., C, B., E, D., W, G., & MA, B. (2024). Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: A comparison between basal-bolus insulin and correctional insulin. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 27, 13074. https://doi.org/10.3389/jpps.2024.13074
Chicago Style (17th ed.) CitationCJ, Yang, Bourgeois C, Delgado E, Graham W, and Burmeister MA. "Real-world Community Hospital Hyperglycemia Management in Noncritically Ill, Type 2 Diabetic Patients: A Comparison Between Basal-bolus Insulin and Correctional Insulin." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques 27 (2024): 13074. https://doi.org/10.3389/jpps.2024.13074.
MLA (9th ed.) CitationCJ, Yang, et al. "Real-world Community Hospital Hyperglycemia Management in Noncritically Ill, Type 2 Diabetic Patients: A Comparison Between Basal-bolus Insulin and Correctional Insulin." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, vol. 27, 2024, p. 13074, https://doi.org/10.3389/jpps.2024.13074.